|
|
|
|
|
Indiana
|
|
0-5534
|
|
35-0160330
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|||
111 Congressional Boulevard, Carmel IN |
|
46032
|
||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
(d) |
Exhibits.
|
● |
Gross premiums written increased 5.9% for the fourth quarter of 2018
compared to the prior year and 15.4% during the full year of 2018 compared to the prior year.
|
● |
Net investment income increased 6.7% for the fourth quarter of 2018
compared to the prior year and 21.8% during the full year of 2018 compared to the prior year.
|
● |
Combined ratio of 112.2% for the fourth quarter of 2018 and 108.6% for
the full year of 2018.
|
5% Increase in Ultimate Loss Ratio
|
10% Increase in Ultimate Loss Ratio
|
|||||||
Gross loss expense from further strengthening current reserve position
|
$
|
34.4
|
$
|
68.7
|
||||
Net financial loss
|
9.0
|
17.6
|
||||||
$/share (after tax)
|
$
|
0.60
|
$
|
1.18
|
Three Months Ended
|
Twelve Months Ended
|
|||||||||||||||
December 31
|
December 31
|
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Income (loss) before federal income taxes (benefits)
|
$
|
(31,674
|
)
|
$
|
10,506
|
$
|
(43,872
|
)
|
$
|
10,122
|
||||||
Less: Net realized gains (losses) on investments
|
(8,391
|
)
|
198
|
(6,651
|
)
|
7,217
|
||||||||||
Less: Net unrealized gains (losses) - equity securities and limited partnerships
|
(11,705
|
)
|
3,954
|
(19,040
|
)
|
12,469
|
||||||||||
Less: Goodwill impairment charge included in Other operating expenses
|
(3,152
|
)
|
-
|
(3,152
|
)
|
-
|
||||||||||
Income (loss) from core business operations
|
$
|
(8,426
|
)
|
$
|
6,354
|
$
|
(15,029
|
)
|
$
|
(9,564
|
)
|
|||||
Less: Net investment income
|
6,038
|
5,661
|
22,048
|
18,095
|
||||||||||||
Underwriting income (loss)
|
$
|
(14,464
|
)
|
$
|
693
|
$
|
(37,077
|
)
|
$
|
(27,659
|
)
|
Unaudited Condensed Consolidated Balance Sheets
|
||||||||
(in thousands, except per share data)
|
||||||||
December 31
|
December 31
|
|||||||
2018
|
2017
|
|||||||
Assets
|
||||||||
Investments 1:
|
||||||||
Fixed maturities (2018: $600,504;
2017: $521,017)
|
$
|
592,645
|
$
|
521,853
|
||||
Equity securities
|
66,422
|
201,763
|
||||||
Limited partnerships, at equity
|
55,044
|
70,806
|
||||||
Commercial mortgage loans
|
6,672
|
-
|
||||||
Short-term 2
|
1,000
|
1,000
|
||||||
721,783
|
795,422
|
|||||||
Cash and cash equivalents
|
163,996
|
64,680
|
||||||
Restricted cash and cash equivalents
|
6,815
|
4,033
|
||||||
Accounts receivable
|
102,972
|
87,551
|
||||||
Reinsurance recoverable
|
392,436
|
318,331
|
||||||
Other assets
|
88,426
|
80,061
|
||||||
Current federal income taxes
|
7,441
|
6,938
|
||||||
Deferred federal income taxes
|
6,262
|
-
|
||||||
$
|
1,490,131
|
$
|
1,357,016
|
|||||
Liabilities and shareholders' equity
|
||||||||
Reserves for losses and loss expenses
|
$
|
865,339
|
$
|
680,274
|
||||
Reserves for unearned premiums
|
71,625
|
53,085
|
||||||
Borrowings under line of credit
|
20,000
|
20,000
|
||||||
Accounts payable and other liabilities
|
177,085
|
170,488
|
||||||
Deferred federal income taxes
|
-
|
14,358
|
||||||
1,134,049
|
938,205
|
|||||||
Shareholders' equity:
|
||||||||
Common stock-no par value
|
634
|
642
|
||||||
Additional paid-in capital
|
54,720
|
55,078
|
||||||
Accumulated other comprehensive income ( loss)
|
(7,347
|
)
|
46,391
|
|||||
Retained earnings
|
308,075
|
316,700
|
||||||
356,082
|
418,811
|
|||||||
$
|
1,490,131
|
$
|
1,357,016
|
|||||
Number of common and common
|
||||||||
equivalent shares outstanding
|
14,869
|
15,047
|
||||||
Book value per outstanding share
|
$
|
23.95
|
$
|
27.83
|
||||
1 2018 & 2017 cost in parentheses
|
||||||||
2 Approximates cost
|
Unaudited Condensed Consolidated Statements of Operations
|
||||||||||||||||
(in thousands, except per share data)
|
||||||||||||||||
Three Months Ended
|
Twelve Months Ended
|
|||||||||||||||
December 31
|
December 31
|
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Revenues
|
||||||||||||||||
Net premiums earned
|
$
|
118,671
|
$
|
97,075
|
$
|
432,880
|
$
|
328,145
|
||||||||
Net investment income
|
6,038
|
5,661
|
22,048
|
18,095
|
||||||||||||
Commissions and other income
|
2,443
|
1,520
|
9,932
|
5,308
|
||||||||||||
Net realized gains (losses) on investments, excluding impairment losses
|
(8,372
|
)
|
278
|
(6,632
|
)
|
7,366
|
||||||||||
Other-than-temporary impairment losses on investments
|
(19
|
)
|
(80
|
)
|
(19
|
)
|
(149
|
)
|
||||||||
Net unrealized gains (losses) on equity securities and limited partnership investments
|
(11,705
|
)
|
3,954
|
(19,040
|
)
|
12,469
|
||||||||||
Net realized and unrealized gains (losses) on investments
|
(20,096
|
)
|
4,152
|
(25,691
|
)
|
19,686
|
||||||||||
107,056
|
108,408
|
439,169
|
371,234
|
|||||||||||||
Expenses
|
||||||||||||||||
Losses and loss expenses incurred
|
101,537
|
66,492
|
345,864
|
247,518
|
||||||||||||
Other operating expenses
|
37,193
|
31,410
|
137,177
|
113,594
|
||||||||||||
138,730
|
97,902
|
483,041
|
361,112
|
|||||||||||||
Income (loss) before federal income tax expense (benefit)
|
(31,674
|
)
|
10,506
|
(43,872
|
)
|
10,122
|
||||||||||
Federal income tax benefit
|
(7,107
|
)
|
(5,970
|
)
|
(9,797
|
)
|
(8,201
|
)
|
||||||||
Net income (loss)
|
$
|
(24,567
|
)
|
$
|
16,476
|
$
|
(34,075
|
)
|
$
|
18,323
|
||||||
Per share data - diluted:
|
||||||||||||||||
Income (loss) before net gains (losses) on investments
|
$
|
(.58
|
)
|
$
|
.92
|
$
|
(.92
|
)
|
$
|
.37
|
||||||
Net gains (losses) on investments
|
(1.07
|
)
|
.18
|
(1.36
|
)
|
.84
|
||||||||||
Net income (loss)
|
$
|
(1.65
|
)
|
$
|
1.10
|
$
|
(2.28
|
)
|
$
|
1.21
|
||||||
Dividends
|
$
|
.28
|
$
|
.27
|
$
|
1.12
|
$
|
1.08
|
||||||||
Reconciliation of shares outstanding:
|
||||||||||||||||
Average shares outstanding - basic
|
14,867
|
15,010
|
14,965
|
15,065
|
||||||||||||
Dilutive effect of share equivalents
|
-
|
35
|
-
|
42
|
||||||||||||
Average shares outstanding - diluted
|
14,867
|
15,045
|
14,965
|
15,107
|
Unaudited Condensed Consolidated Statements of Cash Flows
|
||||||||
(in thousands)
|
||||||||
Twelve Months Ended
|
||||||||
December 31
|
||||||||
2018
|
2017
|
|||||||
Net cash provided by operating activities
|
$
|
100,708
|
$
|
97,744
|
||||
Investing activities:
|
||||||||
Purchases of available-for-sale investments
|
(415,326
|
)
|
(436,932
|
)
|
||||
Purchases of limited partnership interests
|
(450
|
)
|
(1,097
|
)
|
||||
Proceeds from sales or maturities
|
||||||||
of available-for-sale investments
|
454,659
|
350,031
|
||||||
Net purchases of short-term investments
|
-
|
500
|
||||||
Purchase of insurance company-owned life insurance
|
(10,000
|
)
|
-
|
|||||
Purchase of commercial mortgage loans
|
(6,672
|
)
|
-
|
|||||
Distributions from limited partnerships
|
6,869
|
19,230
|
||||||
Other investing activities
|
(5,429
|
)
|
(6,079
|
)
|
||||
Net cash provided by (used in) investing activities
|
23,651
|
(74,347
|
)
|
|||||
Financing activities:
|
||||||||
Dividends paid to shareholders
|
(16,835
|
)
|
(16,302
|
)
|
||||
Repurchase of common shares
|
(4,596
|
)
|
(1,880
|
)
|
||||
Net cash used in financing activities
|
(21,431
|
)
|
(18,182
|
)
|
||||
Effect of foreign exchange rates on cash and cash equivalents
|
(830
|
)
|
522
|
|||||
Increase in cash, cash equivalents and restricted cash
|
102,098
|
5,737
|
||||||
Cash, cash equivalents and restricted cash at beginning of period
|
68,713
|
62,976
|
||||||
Cash, cash equivalents and restricted cash at end of period
|
$
|
170,811
|
$
|
68,713
|
Protective Insurance Corporation and Subsidiaries
|
||||||||||||||||
(In thousands, except per share data)
|
Three Months Ended
|
Twelve Months Ended
|
||||||||||||||
December 31
|
Decmeber 31
|
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Annualized
|
||||||||||||||||
Book value per share beginning of period
|
$
|
25.96
|
$
|
26.93
|
$
|
27.83
|
$
|
26.81
|
||||||||
Book value per share end of period
|
23.95
|
27.83
|
23.95
|
27.83
|
||||||||||||
Change in book value per share
|
$
|
(2.01
|
)
|
$
|
0.90
|
$
|
(3.88
|
)
|
$
|
1.02
|
||||||
Dividends paid
|
0.28
|
0.27
|
1.12
|
1.08
|
||||||||||||
Change in book value per share plus dividends paid
|
$
|
(1.73
|
)
|
$
|
1.17
|
$
|
(2.76
|
)
|
$
|
2.10
|
||||||
Total value creation 1
|
(26.7
|
%)
|
17.4
|
%
|
(9.9
|
%)
|
7.8
|
%
|
||||||||
Return on average shareholders' equity:
|
||||||||||||||||
Average shareholders' equity
|
372,064
|
411,871
|
387,447
|
411,578
|
||||||||||||
Net income (loss)
|
(24,567
|
)
|
16,476
|
(34,075
|
)
|
18,323
|
||||||||||
Less: Net realized gains (losses) on investments, net of tax
|
(15,876
|
)
|
2,699
|
(20,296
|
)
|
12,796
|
||||||||||
Less: Goodwill impairment charge, net of tax
|
(2,490
|
)
|
-
|
(2,490
|
)
|
-
|
||||||||||
Net operating income (loss)
|
(6,201
|
)
|
13,777
|
(11,289
|
)
|
5,527
|
||||||||||
Return on net income (loss) 2
|
(26.4
|
%)
|
16.0
|
%
|
(8.8
|
%)
|
4.5
|
%
|
||||||||
Return on net operating income (loss) 2
|
(6.7
|
%)
|
13.4
|
%
|
(2.9
|
%)
|
1.3
|
%
|
||||||||
Loss and LAE expenses incurred
|
$
|
101,537
|
$
|
66,492
|
$
|
345,864
|
$
|
247,518
|
||||||||
Net premiums earned
|
118,671
|
97,075
|
432,880
|
328,145
|
||||||||||||
Loss and LAE ratio
|
85.6
|
%
|
68.5
|
%
|
79.9
|
%
|
75.4
|
%
|
||||||||
Other operating expenses, excluding goodwill impairment charge
|
$
|
34,041
|
$
|
31,410
|
$
|
134,025
|
$
|
113,594
|
||||||||
Less: Commissions and other income
|
2,443
|
1,520
|
9,932
|
5,308
|
||||||||||||
Other operating expenses, exluding goodwill impairment charge, less commissions and other income
|
$
|
31,598
|
$
|
29,890
|
$
|
124,093
|
$
|
108,286
|
||||||||
Net premiums earned
|
118,671
|
97,075
|
432,880
|
328,145
|
||||||||||||
Expense ratio
|
26.6
|
%
|
30.8
|
%
|
28.7
|
%
|
33.0
|
%
|
||||||||
Combined ratio 3
|
112.2
|
%
|
99.3
|
%
|
108.6
|
%
|
108.4
|
%
|
||||||||
Gross premiums written
|
$
|
152,709
|
$
|
144,179
|
$
|
582,500
|
$
|
504,737
|
||||||||
Net premiums written
|
119,696
|
106,930
|
444,398
|
353,389
|
||||||||||||
1 Total Value Creation equals change in book value plus dividends paid, divided by beginning book
value. Quarterly amounts have been annualized.
|
||||||||||||||||
2 Quarterly amounts have been annualized
|
||||||||||||||||
3 The combined ratio is calculated as ratio of losses and loss expenses incurred, plus other operating
expenses excluding goodwill impairment charge, less commission and other income to net premiums earned.
|
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end